Fabrizia Corona Selected Research

Juvenile Arthritis (Juvenile Idiopathic Arthritis)

12/2018	Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials.
12/2016	Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept.
1/2015	May biscuits contribute to iron balance? An observation in children with juvenile idiopatic arthritis.
11/2014	Immunogenicity, safety and tolerability of a bivalent human papillomavirus vaccine in adolescents with juvenile idiopathic arthritis.
8/2014	Farber disease in infancy resembling juvenile idiopathic arthritis: identification of two new mutations and a good early response to allogeneic haematopoietic stem cell transplantation.
1/2013	Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry.
1/2012	Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis.
4/2010	Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial.
5/2008	Knee synovectomy in children with juvenile idiopathic arthritis.
7/2004	A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fabrizia Corona Research Topics

Disease

11	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 12/2018 - 03/2003
2	Infections 02/2016 - 10/2014
2	Dermatomyositis (Dermatopolymyositis) 02/2016 - 01/2011
2	Farber Lipogranulomatosis 01/2016 - 08/2014
2	Inflammation (Inflammations) 01/2015 - 04/2010
2	Uveitis 01/2013 - 05/2007
2	Arthritis (Polyarthritis) 05/2008 - 05/2007
1	Pericarditis 09/2016
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2016
1	Anterior Uveitis 01/2013
1	Localized Scleroderma (Morphea) 09/2010
1	Lipodystrophy 09/2009
1	Psoriatic Arthritis 05/2008
1	Thrombophlebitis 05/2008
1	Infectious Arthritis (Septic Arthritis) 05/2008
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2006
1	autosomal dominant familial Periodic fever 03/2006
1	Fever (Fevers) 03/2005
1	Rheumatic Diseases (Rheumatism) 08/2002

Drug/Important Bio-Agent (IBA)

3	Methotrexate (Mexate)FDA LinkGeneric 02/2016 - 07/2004
2	Etanercept (Enbrel)FDA Link 12/2016 - 01/2012
2	Ferritins (Ferritin)IBA 01/2015 - 10/2014
1	canakinumab FDA Link 12/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2016
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2016
1	Colchicine FDA LinkGeneric 09/2016
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2016
1	Prednisone (Sone)FDA LinkGeneric 02/2016
1	IronIBA 01/2015
1	FumaratesIBA 01/2015
1	Papillomavirus Vaccines (HPV Vaccines)IBA 11/2014
1	Adalimumab (Humira)FDA Link 01/2013
1	Infliximab (Remicade)FDA Link 01/2013
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2012
1	Antirheumatic Agents (DMARD)IBA 01/2012
1	CollagenIBA 09/2010
1	Glucose (Dextrose)FDA LinkGeneric 09/2009
1	LipidsIBA 09/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2006
1	EnzymesIBA 03/2005
1	mevalonate kinaseIBA 03/2005
1	Immunoglobulin D (IgD)IBA 03/2005
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 08/2002

Therapy/Procedure

8	Therapeutics 09/2016 - 08/2002
1	Time-to-Treatment 02/2016
1	Hematopoietic Stem Cell Transplantation 01/2016
1	Denervation 01/2016
1	Stem Cell Transplantation 08/2014
1	Drug Therapy (Chemotherapy) 01/2011
1	Synovectomy 05/2008